In human KCs, the overexpression of RANTES induced by IFN-γ and IL-4 is significantly reduced by 10−8 or 10−6 M of tacrolimus, indicating its possible role in the amelioration of AD through KCs targeting [275]. Here, CCL5 is linked to Alzheimer disease.